Chaoling Chen

Also affiliated with Virginia Commonwealth University Medical Center

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Inactivation of fatty acid amide hydrolase protects against ischemic reperfusion injury-induced renal fibrogenesis”.

Inactivation of fatty acid amide hydrolase protects against ischemic reperfusion injury-induced renal fibrogenesis

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease(2022)10.1016/j.bbadis.2022.166456

N/A

0DataRank · unranked

11 citations

Weili Wang, Justin L. Poklis, Aron H. Lichtman, Joseph K. Ritter, Gaizun Hu +3 more

Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice

Molecular Pharmacology(2023)10.1124/molpharm.122.000618

N/A

0DataRank · unranked

12 citations

Weili Wang, Marissa Raymond, Fereshteh Ahmadinejad, Justin L. Poklis, Brandon Em +4 more

Oral administration of BAF312, a selective sphingosine-1-phosphate receptor agonist, attenuates sodium retention and hypertension in DOCA-salt-treated mice

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.122.213140

N/A

0DataRank · unranked

0 citations

Gaizun Hu, Chaoling Chen, Joseph K. Ritter, Pin‐Lan Li, Ningjun Li +1 more

Mitigation of cisplatin-induced acute kidney injury through oral administration of fatty acid amide hydrolase inhibitor PF-04457845

Journal of Pharmacology and Experimental Therapeutics(2024)10.1124/jpet.124.002282

N/A

0DataRank · unranked

8 citations

Weili Wang, Justin L. Poklis, Pin-Lan Li, Aron H. Lichtman, David A. Gewirtz +2 more